Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy.

Alessi A, Lorenzoni A, Cavallo A, Padovano B, Iacovelli NA, Bossi P, Alfieri S, Serafini G, Colombo CB, Cicchetti A, Mira M, Licitra L, Fallai C, Crippa F, Orlandi E.

Radiol Med. 2018 Dec 17. doi: 10.1007/s11547-018-0980-6. [Epub ahead of print]

PMID:
30560502
2.

Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases.

Pietrantonio F, Cotsoglou C, Fucà G, Lo Vullo S, Nichetti F, Milione M, Coppa J, Vaiani M, Alessi A, Prisciandaro M, Droz-Dit Busset M, Morano F, Corallo S, Lazzati S, Antista M, Mennitto A, Randon G, Raimondi A, Belfiore A, Padovano B, Perrone F, Mariani L, Di Bartolomeo M, de Braud F, Mazzaferro V.

Clin Colorectal Cancer. 2018 Nov 24. pii: S1533-0028(18)30212-3. doi: 10.1016/j.clcc.2018.11.004. [Epub ahead of print]

PMID:
30558859
3.

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME).

Imbimbo M, Ottaviano M, Vitali M, Fabbri A, Leuzzi G, Fiore M, Franceschini D, Pasello G, Perrino M, Schiavon M, Pruneri G, Dei Tos AP, Sangalli C, Garassino MC, Berardi R, Alessi A, Calareso G, Petrini I, Scorsetti M, Scotti V, Rosso L, Rea F, Pastorino U, Casali PG, Ramella S, Ricardi U, Abate-Daga L, Torri V, Trama A, Palmieri G, Marino M, Zucali PA; TYME network collaborators.

Cancer Treat Rev. 2018 Dec;71:76-87. doi: 10.1016/j.ctrv.2018.10.001. Epub 2018 Oct 5.

PMID:
30366202
4.

Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure.

Necchi A, Raggi D, Giannatempo P, Alessi A, Serafini G, Colecchia M, Ali SM, Chung JH.

Eur J Cancer. 2018 Jun;96:128-130. doi: 10.1016/j.ejca.2018.03.021. Epub 2018 Apr 18. No abstract available.

PMID:
29680362
5.

Management of Metastatic Collecting Duct Carcinoma: An Encouraging Result in a Patient Treated With Cabozantinib.

Mennitto A, Verzoni E, Peverelli G, Alessi A, Procopio G.

Clin Genitourin Cancer. 2018 Jun;16(3):e521-e523. doi: 10.1016/j.clgc.2018.03.010. Epub 2018 Mar 27. No abstract available.

PMID:
29656939
6.

Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions.

Berenato R, Morano F, Pietrantonio F, Cotsoglou C, Caporale M, Infante G, Pellegrinelli A, Alessi A, Battiston C, Coppa J, Padovano B, Mennitto A, Niger M, Fucà G, Lazzati S, Greco G, Delconte G, de Braud F, Mazzaferro V, Di Bartolomeo M.

Oncology. 2017;93(5):279-286. doi: 10.1159/000479154. Epub 2017 Sep 8.

PMID:
28881354
7.

Photophysical properties and excited state dynamics of 4,7-dithien-2-yl-2,1,3-benzothiadiazole.

Iagatti A, Patrizi B, Basagni A, Marcelli A, Alessi A, Zanardi S, Fusco R, Salvalaggio M, Bussotti L, Foggi P.

Phys Chem Chem Phys. 2017 May 31;19(21):13604-13613. doi: 10.1039/c6cp08721c.

PMID:
28518198
8.

Photoactivated processes in optical fibers: generation and conversion mechanisms of twofold coordinated Si and Ge atoms.

Giacomazzi L, Martin-Samos L, Boukenter A, Ouerdane Y, Girard S, Alessi A, Gironcoli S, Richard N.

Nanotechnology. 2017 May 12;28(19):195202. doi: 10.1088/1361-6528/aa693b. Epub 2017 Mar 27.

PMID:
28345535
9.

Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.

Pietrantonio F, Di Bartolomeo M, Cotsoglou C, Mennitto A, Berenato R, Morano F, Coppa J, Perrone F, Iacovelli R, Milione M, Alessi A, Vaiani M, Bossi I, Ricchini F, Scotti M, Caporale M, Bajetta E, de Braud F, Mazzaferro V.

Clin Colorectal Cancer. 2017 Sep;16(3):e191-e198. doi: 10.1016/j.clcc.2016.09.007. Epub 2016 Oct 6.

PMID:
27979717
10.

7th Brazilian Guideline of Arterial Hypertension: Chapter 2 - Diagnosis and Classification

Malachias MVB, Gomes MAM, Nobre F, Alessi A, Feitosa AD, Coelho EB.

Arq Bras Cardiol. 2016 Sep;107(3 Suppl 3):7-13. doi: 10.5935/abc.20160152. English, Portuguese. No abstract available.

11.

MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer.

Pietrantonio F, Oddo D, Gloghini A, Valtorta E, Berenato R, Barault L, Caporale M, Busico A, Morano F, Gualeni AV, Alessi A, Siravegna G, Perrone F, Di Bartolomeo M, Bardelli A, de Braud F, Di Nicolantonio F.

Cancer Discov. 2016 Sep;6(9):963-71. doi: 10.1158/2159-8290.CD-16-0297. Epub 2016 Jun 20.

12.

Self-entrainment to optimal gaits of an underactuated biomimetic swimming robot using adaptive frequency oscillators.

Alessi A, Accoto D, Guglielmelli E.

Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:3627-30. doi: 10.1109/EMBC.2015.7319178.

PMID:
26737078
13.

Enhanced energy transport in genetically engineered excitonic networks.

Park H, Heldman N, Rebentrost P, Abbondanza L, Iagatti A, Alessi A, Patrizi B, Salvalaggio M, Bussotti L, Mohseni M, Caruso F, Johnsen HC, Fusco R, Foggi P, Scudo PF, Lloyd S, Belcher AM.

Nat Mater. 2016 Feb;15(2):211-6. doi: 10.1038/nmat4448. Epub 2015 Oct 12.

PMID:
26461447
14.

Interim (18)F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future Directions.

Necchi A, Nicolai N, Alessi A, Miceli R, Giannatempo P, Raggi D, Tana S, Serafini G, Padovano B, Mariani L, Crippa F, Salvioni R.

Clin Genitourin Cancer. 2016 Jun;14(3):249-54. doi: 10.1016/j.clgc.2015.08.010. Epub 2015 Sep 5.

PMID:
26433626
15.

FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results.

Alessi A, Martinelli F, Padovano B, Serafini G, Lorusso D, Lorenzoni A, Ditto A, Lecce F, Mira M, Donfrancesco C, Raspagliesi F, Crippa F.

Tumori. 2016 Jan-Feb;102(1):103-7. doi: 10.5301/tj.5000396. Epub 2015 Aug 4.

PMID:
26350201
16.

Determining brain fitness to fight: Has the time come?

Seifert T, Bernick C, Jordan B, Alessi A, Davidson J, Cantu R, Giza C, Goodman M, Benjamin J.

Phys Sportsmed. 2015 Nov;43(4):395-402. doi: 10.1080/00913847.2015.1081551. Epub 2015 Aug 21.

PMID:
26295482
17.

Mon Chéri Haiti: Neurology lessons learned.

Sharma M, Santini V, Auguste M, Hohler AD, Etienne M, Jones E, Alessi A.

Neurology. 2015 Jul 14;85(2):169-71. doi: 10.1212/WNL.0000000000001735. No abstract available.

PMID:
26170399
18.

¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study.

Crippa F, Agresti R, Sandri M, Mariani G, Padovano B, Alessi A, Bianchi G, Bombardieri E, Maugeri I, Rampa M, Carcangiu ML, Trecate G, Pascali C, Bogni A, Martelli G, de Braud F.

Eur J Nucl Med Mol Imaging. 2015 May;42(6):818-30. doi: 10.1007/s00259-015-2995-8. Epub 2015 Feb 12.

PMID:
25673053
19.

Design and preliminary testing of an active intramedullary nail.

Letechipia J, Alessi A, Rodríguez G, Asbun J.

Rev Invest Clin. 2014 Jul;66 Suppl 1:S70-8.

PMID:
25264800
20.

Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by PET scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma.

Farina L, Rezzonico F, Spina F, Dodero A, Mazzocchi A, Crippa F, Alessi A, Dalto S, Viviani S, Corradini P.

Biol Blood Marrow Transplant. 2014 Dec;20(12):1982-8. doi: 10.1016/j.bbmt.2014.08.016. Epub 2014 Aug 23.

Supplemental Content

Loading ...
Support Center